NDC 17856-0182-2 - ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0182
- Requested NDC
- 17856-0182-2
- Package NDCs from labels
- 17856-0182-2, 17856-0182-1, 17856-0182-3, 17856-0182-5, 17856-0182-4
- Manufacturer
- ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS
- Effective date
- 2022-11-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACETAMINOPHEN - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2022-11-14 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0182-3 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fb3f-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
| 17856-0182-4 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fb3f-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0182-1 | ACETAMINOPHEN | 120 in 1 BOX, UNIT-DOSE | ELIXIR | 120 | 3 | |
| 17856-0182-2 | ACETAMINOPHEN | 2 mL in 1 SYRINGE | ELIXIR | 2 | 3 | |
| 17856-0182-3 | ACETAMINOPHEN | 5 in 1 SYRINGE | ELIXIR | 5 | 3 | |
| 17856-0182-4 | ACETAMINOPHEN | 72 in 1 BOX, UNIT-DOSE | ELIXIR | 72 | 3 | |
| 17856-0182-5 | ACETAMINOPHEN | 5 mL in 1 CUP, UNIT-DOSE | ELIXIR | 5 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0182 | ACETAMINOPHEN ELIXIR [ATLANTIC BIOLOGICALS CORP.] | 3 | Legacy NDC, 5 package rows | 20221115_cf2dd95d-afea-462d-9dba-a46a68bf67e6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0182-4 | ML - Milliliter | 17856-0182 | 095990e2-50ba-4bb4-a465-af7821d7ccb3 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topcare DayTime Cold and Flu Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | Topco Associates LLC | bb9663e3-fd11-4e72-bf85-fee4841b795f | 2025-07-15 | Warnings | 362O9ITL9D |
| Berkley and Jensen Pain Relief | ACETAMINOPHEN | BJWC | d3ee3341-93b8-487c-921e-2892d213efbb | 2025-07-15 | Warnings | 362O9ITL9D |
| DG HEALTH COLD FLU RELIEF | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | Dolgencorp Inc | 320e4f32-66aa-48be-9afd-fa2b2c217dc1 | 2025-07-14 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Upsher-Smith Laboratories, LLC | 3aa0b733-b58f-46bd-8e76-37ddf1dc3356 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Nikzon Hemorrhoidal | GLYCERIN, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, AND PRAMOXINE HYDROCHLORIDE | Genomma Lab USA | 8f9a9939-2c99-489f-b597-9a51ec2684f9 | 2025-07-14 | Warnings | PDC6A3C0OX |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy | 9e459853-5951-4ae7-88a6-85b502e9dd41 | 2025-07-14 | Warnings | 362O9ITL9D |
| EXTRA PAIN RELIEF | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | TIME CAP LABS | 59482917-f80b-4bed-9218-068b35366eb3 | 2025-07-11 | Warnings | 362O9ITL9D |
| CVS PHARMACY MS Adult Severe Multi Symptom Cough Cold Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | CVS PHARMACY | cdc9af7c-3766-4573-9d95-bf217907b932 | 2025-07-11 | Warnings | 362O9ITL9D |
| HEADACHE RELIEF | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Kroger Company | bbed29a1-3c52-3531-e053-2995a90a686c | 2025-07-10 | Warnings | 362O9ITL9D |
| Nighttime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | CVS PHARMACY, INC | b765c82e-5021-4772-8647-c5ebc596bc0a | 2025-07-10 | Warnings | 362O9ITL9D |
| Up and Up Childrens acetaminophen | ACETAMINOPHEN | Target Corporation | 25a476a4-9969-49b3-94bf-b076bada4cea | 2025-07-10 | Warnings | 362O9ITL9D |
| Sinus Pressure and Pain | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Walgreen Company | c378acaf-389a-4afb-a4f0-e367a907a468 | 2025-07-10 | Warnings | 362O9ITL9D |
| Tylenol Extra Strength Caplet | ACETAMINOPHEN | Jones Healthcare Group - Packaging Services, Inc | fba711c1-4e69-49b0-8994-97c455aebcb2 | 2025-07-09 | Warnings | 362O9ITL9D |
| ACTIDOGESIC DF | ACETAMINOPHEN, DEXBROMPHENIRAMINE MALEATE | ACTIPHARMA, LLC | ff8e2565-bce3-4c06-a416-6e8f369f057f | 2025-07-09 | Warnings | 362O9ITL9D |
| Maximum Strength Hemorrhoidal Cream with Aloe | GLYCERIN, PHENYLEPHINE HCI, PRAMOXINE HCI, PETROLATUM | Chain Drug Marketing Association | 396ea654-8be1-591a-e063-6294a90a11e2 | 2025-07-08 | Warnings | PDC6A3C0OX |
| Daytime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | P & L Development, LLC | 0bb006f6-c360-4cd5-81e9-0776d99d79e8 | 2025-07-08 | Warnings | 362O9ITL9D |
| good sense pain relief | ACETAMINOPHEN | L. Perrigo Company | af7ae548-38ad-41d5-b1cb-761cd2e386d3 | 2025-07-08 | Warnings | 362O9ITL9D |
| Nighttime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | CVS PHARMACY, INC | f59016f3-a8f8-4c95-9414-01440f0574d9 | 2025-07-08 | Warnings | 362O9ITL9D |
| topcare pain relief | ACETAMINOPHEN | Topco Associates LLC | 6aca88df-d3b5-4a60-b23b-1e66dc41ee7b | 2025-07-08 | Warnings | 362O9ITL9D |
| Nighttime Cold and Flu Maximum Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCI, PHENYLEPHRINE HCI | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 776b7c67-56c7-420c-82b2-9a176d998396 | 2025-07-08 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.